Point State Capital LP Pfizer Inc Call Options Transaction History

Point State Capital LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $1.96 Million - $2.52 Million	-50,000 Reduced 25.0%	150,000 $6.45 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $3.59 Million - $4.07 Million	-100,000 Reduced 33.33%	200,000 $7.83 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $8.37 Million - $9.44 Million	250,000 Added 500.0%	300,000 $10.9 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $1.67 Million - $2.13 Million	50,000 New	50,000 $1.84 Million

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.